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Objective: Platelet-rich plasma (PRP) is reported to promote collagen synthesis and cell proliferation as
well as enhance cartilage repair. Our previous study revealed that the intracapsular injection of muscle
derived stem cells (MDSCs) expressing bone morphogenetic protein 4 (BMP-4) combined with soluble
Flt-1 (sFlt1) was effective for repairing articular cartilage (AC) after osteoarthritis (OA) induction. The
current study was undertaken to investigate whether PRP could further enhance the therapeutic effect of
MDSC therapy for the OA treatment.
Methods: MDSCs expressing BMP-4 and sFlt1 were mixed with PRP and injected into the knees of
immunodeﬁcient rats with chemically induced OA. Histological assessments were performed 4 and 12
weeks after cell transplantation. Moreover, to elucidate the repair mechanisms, we performed in vitro
assays to assess cell proliferation, adhesion, migration and mixed pellet co-culture of MDSCs and OA
chondrocytes.
Results: The addition of PRP to MDSCs expressing BMP-4 and sFlt1 signiﬁcantly improved AC repair
histologically at week 4 compared to MDSCs expressing BMP-4 and sFlt1 alone. Higher numbers of cells
producing type II collagen and lower levels of chondrocyte apoptosis were observed by MDSCs
expressing BMP-4 and sFlt1 and mixed with PRP. In the in vitro experiments, the addition of PRP
promoted proliferation, adhesion and migration of the MDSCs. During chondrogenic pellet culture, PRP
tended to increase the number of type II collagen producing cells and in contrast to the in vivo data, it
increased cell apoptosis.
Conclusions: Our ﬁndings indicate that PRP can promote the therapeutic potential of MDSCs expressing
BMP-4 and sFlt1 for AC repair (4 weeks post-treatment) by promoting collagen synthesis, suppressing
chondrocyte apoptosis and ﬁnally by enhancing the integration of the transplanted cells in the repair
process.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Platelet-rich plasma (PRP) is deﬁned as an autologous concen-
tration of platelets in a small volume of plasmawhich is considered
to be a rich source of autologous growth factors1. Recently, there has
been a great interest in the use of PRP for the treatment of ortho-
pedics-related injuries2. PRP contains numerous growth factors andJ. Huard, Stem Cell Research
ve, 2 Bridgeside Point, Suite
Fax: 1-412-648-4066.
s Research Society International. Pbioactive proteins in the alpha-granules of blood platelets1,3e6. It
has been reported that PRP can promote angiogenesis, collagen
synthesis and cell proliferation, and is capable of positively inﬂu-
encing the healing of tendon, ligament, skeletalmuscle, and bone7,8.
In regard to articular cartilage (AC), it has been reported that PRP
stimulates porcine chondrocyte proliferation and matrix biosyn-
thesis9, as well as having the ability to enhance the chondrogenic
differentiation capacity ofmesenchymal stemcells (MSCs) in vitro10.
Furthermore, some in vivo studies also showed that chondrocyte/
PRP composites could enhance the regeneration of AC defects11 and
that PRP, in a poly-lactic-glycolic acid scaffold, could improve
osteochondral healing in a rabbit model12.ublished by Elsevier Ltd. All rights reserved.
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derived stem cells (MDSCs) for the treatment of various diseases
and conditions of the musculoskeletal system because of their
ability to undergo multilineage differentiation13e19. More impor-
tantly for the current investigation, we have reported that MDSCs
can undergo chondrogenesis in vivo and in vitro20,21, and that bone
morphogenetic protein 4 (BMP-4)-transduced MDSCs could
improve AC regeneration after injury22. Moreover, we have shown
that soluble Flt-1 (sFlt1; a vascular endothelial growth factor
(VEGF) antagonist)/BMP-4 transduced MDSCs could enhance
cartilage regeneration in rats with induced osteoarthritis (OA)
when transplanted intra-articularly by blocking the intrinsic VEGF
catabolic pathway and extrinsic VEGF-induced vascular invasion
which prevents chondrocyte apoptosis23. These results taken
together showed that blocking angiogenesis, combinedwith BMP-4
expressing MDSCs was effective for OA repair. Despite the fact that
PRP contains many growth factors and cytokines that promote
angiogenesis, PRP has been reported to have a positive effect on
cartilage repair9e12. In the current study, we performed a set of
experiments in a rat model of OA designed to investigate whether
PRP could enhance the therapeutic effect that MDSCs have on OA
injured AC, and also determined whether PRP could further
increase the beneﬁcial effects that retroviral constructs expressing
sFlt1 and BMP-4 have on MDSC mediated AC repair during OA.Materials and methods
Isolation of MDSCs and PRP preparation
MDSCswere isolated from the hind-limb skeletal muscle of C57-
BL10J mice, (Jackson Laboratory, Bar Harbor, ME) via a modiﬁed
preplate technique, and MDSCs were transduced separately with
retroviral vectors encoding for green ﬂuorescent protein (GFP),
BMP-4 and GFP (B4eGFP) or sFlt1 and LacZ (sFlt1eLacZ) as previ-
ously described23. PRP was isolated from the whole blood of nude
rats (NIH-Whn NIHRNU-M; Taconic, NY, USA) via a double centri-
fugation technique as previously described24.Repair of MIA-induced arthritis
The animal experiments performed in this study were
approved by the Institutional Animal Care and Use Committee at
University of Pittsburgh. Thirty-six female nude rats (NIH-Whn
NIHRNU-M; Taconic) were used in this study. The animals were
anesthetized with 3% isoﬂuorane in O2 gas (1.5 L/min). OA-like
arthritis was induced by a single intra-articular knee injection of
monosodium iodoacetate (MIA) (Aldrich Chemical, Milwaukee,
WI) (0.3 mg/150 mg body weight) into the bilateral knee joints of
the rats. Two weeks after MIA injection, each group of rats had
their knee joints treated as described in Table I. Rats were sacri-
ﬁced 4 and 12 weeks after cell transplantation (n ¼ 6 OA knees
from three rats in each treatment group for each time point) as
previously described23.Table I
Treatment groups in OA model
Group Cell type




MeB4/sFlt1 þ PRP sFlt1eMDSC/BMP-4eMDSC
MeB4/sFlt1 sFlt1eMDSC/BMP-4eMDSC
We set these six treatment groups in this study.Histological evaluation of cartilage repair
Serial sagittal sections, 5 mm in thickness, were cut and stained
with Safranin Oefast green. We evaluated OA repair semi-
quantitatively using a grading and staging system25. In this
system, there are six histological grades and four histological stages.
The total score (score¼ grade stage) ranging from1 point (normal
AC) to 24 points (no repair) was evaluated by three researchers
blinded to the treatment groups.
Contribution of transduced MDSCs in the cartilage healing process
To detect transplanted mouse cells in the femoral condyle,
immunohistochemistry was performed at week 4 with the following
antibodies; rabbit anti-rat type 2 collagen (Col2) (Sigma) to detect rat
andmouse chondrocytes21, rabbit anti-GFPAlexa Fluor488conjugated
(Molecular Probe, Eugene, OR) for detection of B4eGFPeMDSCs and
GFPeMDSCs, and biotin-conjugated anti-b-galactosidase (b-gal) for
detection of sFlt1eLacZeMDSCs. The numbers of double-positive and
Col2-positive cells were morphometrically counted in ﬁve randomly
selected soft tissue ﬁelds in the femoral condyle by using Northern
Eclipse software (Empix Imaging Inc., Cheektowaga, NY). The
following secondary antibodies were used for each immunostaining:
Alexa Fluor594-conjugateddonkeyanti-rabbit IgG (Molecular Probes)
was used for Col2 staining and Alexa Fluor 488-conjugated goat anti-
mouse IgG (Molecular Probes) was used for GFP and b-gal staining.
Chondrocyte apoptosis analysis
TUNEL assay was performed on the 4-week time point groups
using an Apop Tag Plus Peroxidase In Situ Apoptosis Detection Kit
according to the manufacturer’s instructions (CHEMICON, Teme-
cula, CA). After the staining, the positive signals were examined by
light microscopy (n ¼ 6 knees in each group).
Cell functional assays and mixed pellet culture
To assess the effects of PRP, BMP-4 and sFlt1 on cell function of
MDSCs including proliferation, adhesion and migration, each assay
was performed and the detailed methods and the treatment groups
in these assays are shown in Supplementary Information. Pellet
cultures were also performed with the mixed-cell components.
Mixed pellet cultures consisted of 1105 OA chondrocytes plus: (1)
1  105 BMP-4 transduced MDSCs, (2) 1  105 sFlt1 transduced
MDSCs, or (3) 1  105 non-transduced MDSCs, and each of the
mixed-cell pellets was cultured in chondrogenic medium with or
without PRP for 14 days. Pellets were assessed via Alcian blue and
TUNEL staining (n ¼ 3). The detailed methods of mixed pellet
culture are outlined in the Supplementary Information.
Statistical analysis
All values were expressed as 95% conﬁdence intervals (95% CI).
Comparisons among multiple groups were made using analysis ofCell number (cells) Solution
5.0  105 PRP 30 ml þ PBS 20 ml
5.0  105 PBS 50 ml
0 PRP 30 ml þ PBS 20 ml
0 PBS 50 ml
2.5  105/2.5  105 PRP 30 ml þ PBS 20 ml
2.5  105/2.5  105 PBS 50 ml
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was performed by Fisher’s Protected Least Signiﬁcant Difference
(PLSD) test. The comparisons of histological scores were analyzed
using mixed effects ANOVA using the Statistical Package for Social
Sciences (SPSS) (version 15.0; SPSS Inc., IL, USA). A value of P < 0.05
was considered statistically signiﬁcant.
Results
Platelet count
The platelets found in the PRP used in these studies exhibited
normal morphology. Platelet counts revealed that the PRP prepa-
ration technique produced highly concentrated platelet containing
plasma. PRP smears showed higher concentrations of platelets than
whole blood ones. The average whole blood platelet count was
42.0  104 platelets/mL (95% CI: 34.2  104, 50.7  104), whereas
the average PRP platelet count was 230.0  104 platelets/mL (95%
CI: 171.1104, 275.4  104) which is a 5.5-fold increase in platelets.
Effect of PRP on MDSC mediated AC repair (macroscopic and
histological evaluation of the femoral condyles)
There was no gross evidence of any side effects from the
retroviral transduction such as a reduction in proliferation, changes
in the cell differentiation behavior, nor in their neoplastic trans-
formation behavior throughout the observation period. Four weeks
after MDSC (M) transplantation into the OA model, macroscopic
evaluation of the M þ PRP group showed well-repaired articular
surfaces, though osteophyte formations were detected in some
portions of the experimental animal’s joints [Fig. 1(A)]; however,
the M, PRP and PBS groups showed marked arthritis including
synovial hypertrophy and osteophyte formation. Histologic
assessment demonstrated that Safranin O-positive hyaline-like
cartilage was present in the M þ PRP group [Fig. 1(B)], and was
less prevalent in the M group and was completely absent in both
the PRP and PBS groups.
Twelveweeks after transplantation in theMþ PRP group, the AC
surfaces appeared to be smooth though osteophyte formation was
more advanced than at the 4-week time point. On the other hand,
the M, PRP, and PBS groups all showed a marked progression of
arthritis. Histologic assessment also demonstrated destructive
events including pannus invasion, osteolysis, cyst formation within
the subchondral bone area, and reduction in Safranin O-positive
staining in the PRP and PBS groups. A histological grading scale25
was used to evaluate the quality of the repaired tissues. At 4
weeks following transplantation, the total score of the M þ PRP
group was signiﬁcantly better than the PRP and PBS groups
[P¼ 0.0470 forMþ PRP vs PRP group; P¼ 0.0330 forMþ PRP vs PBS
group (Note that the lower the score the better the cartilage repair)]
[Fig. 1(C)]. Twelve weeks following transplantation, the total score
of the M þ PRP group was still signiﬁcantly better than the PRP and
PBS groups (P ¼ 0.0340 for M þ PRP vs PRP group; P ¼ 0.0060 for
M þ PRP vs PBS group) [Fig. 1(C)]. There were no signiﬁcant differ-
ences between the M þ PRP and M groups at 4 and 12 weeks after
transplantation (week 4, P ¼ 0.1860; week 12, P ¼ 0.2520).
MDSCs contribution to the AC repair process
Double immunohistochemical staining for Col2 and GFP or b-gal
was performed using tissue samples obtained 4 weeks post-
transplantation which would allow the determination of whether
the new chondrocytes were differentiated transplanted MDSCs. All
MDSCs used for M þ PRP and M groups were transduced to express
GFP. GFP-positive cells expressing Col2 were found in the femoralcondyles in all the groups except the PRP and PBS groups [Fig. 2(A)].
Quantiﬁcation of the double-positive stained cells demonstrated
that there was no signiﬁcant difference between the M þ PRP and
the M groups (P ¼ 0.5160) [Fig. 2(B)]; however, the total number of
Col2-positive cells derived from the donor and host cells was found
to be signiﬁcantly higher in the M þ PRP group when compared to
the other groups (P ¼ 0.0060 for M þ PRP vs M; P ¼ 0.0030 for
M þ PRP vs PRP; P ¼ 0.0020 for M þ PRP vs PBS) [Fig. 2(C)].
Chondrocyte apoptosis analyses
Chondrocyte apoptosis was less abundant in the superﬁcial/mid
zone of the femoral condyles in theMþ PRP group when compared
with the PRP and PBS groups [Fig. 2(D)]. Quantiﬁcation of the
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) stained cells showed that the M þ PRP group showed
signiﬁcantly fewer apoptotic chondrocytes compared to the PRP
and PBS groups (P ¼ 0.0050 for M þ PRP vs PRP; P ¼ 0.0020 for
M þ PRP vs PBS), however, there was no signiﬁcant difference
between the M þ PRP and M groups (P ¼ 0.0790) [Fig. 2(E)].
Beneﬁcial effect of PRP on BMP-4 and sFlt1 expressing MDSC
therapy
In the current study, PRP provided only a limited effect on the
regenerative potential of MDSCs toward cartilage repair after OA
(Figs.1 and 2), when comparedwith our previous paper which used
transduced MDSCs23. As PRP contains angiogenic factors that can
have deleterious effects on the AC repair process, and BMP-4 has
been found to be important for MDSC mediated AC repair, we
performed additional experiments using PRP and MDSCs that
expressed both BMP-4 and sFlt1.
MDSCs (M) were retrovirally transduced with sFlt1eLacZ (sFlt1)
or BMP-4eGFP (B4) and then combined at a 1:1 ratio prior to
transplantation (MesFlt1/B4) (Table I). Four weeks after MDSC
transplantation, macroscopic evaluation of the groups revealed
smooth joint surfaces of AC and no osteophyte formation [Fig. 3(A)].
Histologic assessment demonstrated that more Safranin O-positive
hyaline-like cartilage was present in the MesFlt1/B4þ PRP andMe
sFlt1/B4 groups when comparedwith theMþ PRP group [Fig. 3(B)].
Twelveweeks after transplantation, rat knees treatedwithMesFlt1/
B4 þ PRP or MesFlt1/B4 still showed smooth joint surfaces in most
regions of the articular condyles [Fig. 3(A)]. Histologic assessment
also demonstrated that more Safranin O-positive tissue and fewer
clusters of chondrocytes present within necrotic-like-tissue were
found in the MesFlt1/B4 þ PRP and MesFlt1/B4 groups when
compared with the other groups shown in Fig. 1 [Fig. 3(B)].
In thehistological grading scale atweek4, the scoreof theMesFlt1/
B4 þ PRP group was signiﬁcantly better than the MesFlt1/B4 group
(P¼ 0.0020) [Fig. 3(C)]. Twelveweeks following transplantation, there
was no signiﬁcant difference between the MesFlt1/B4 þ PRP and the
MesFlt1/B4 groups (P ¼ 0.2640) [Fig. 3(C)]. Of note, the MesFlt1/
B4 þ PRP and MesFlt1/B4 groups maintained scores similar to the
scores given at the 4-week time point.
Contributions of BMP-4 and sFlt1 expressing MDSCs to the AC repair
process
Differentiated chondrocytes derived from transduced MDSCs
were determined at week 4 by detecting cells double stained for
Col2 and either GFP (MeB4 cells) or b-gal (MesFlt1 cells). Within
the knee, cells were identiﬁed that co-expressed Col2 and GFP or b-
gal [Fig. 4(A and B)]. Quantiﬁcation of the number of double-posi-
tive cells of Col2 and GFP or b-gal demonstrated that the MesFlt1/
B4 þ PRP group showed a signiﬁcantly higher number of double-
Fig. 1. Macroscopic and histologic evaluation of representative rat joints. (A) Four weeks after MDSC transplantation, macroscopic evaluation of the MDSC (M) þ PRP group
showed well-repaired articular surfaces, but some parts of the joints included osteophyte formation. The M, PRP and PBS groups showed marked arthritis including synovial
hypertrophy and osteophyte formation. Twelve weeks after transplantation, in the M þ PRP groups, the AC surfaces tended to be smooth, but osteophyte formation was more
advanced than that at 4 weeks (arrows). The M, PRP, and PBS groups showed marked progression of arthritis, synovial hypertrophy, and osteophyte formation (arrows).
(B) Histologic assessment at week 4 and 12 demonstrated that Safranin O-positive hyaline-like cartilage (red staining) was present in the M þ PRP group, but less prominent in the
M group. Safranin O-positive hyaline-like cartilage was completely absent in both the PRP and PBS groups. Original magniﬁcation 100. (C) Semiquantitative histologic scores for all
groups, 4 and 12 weeks following transplantation. The total score of the M þ PRP group was signiﬁcantly lower than the PRP and the PBS groups at week 4 and 12 (n ¼ 6 knees in
each group).
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Fig. 2. Cell contribution of MDSCs and chondrocyte apoptosis analysis. (A) Double immunohistochemical staining for type II collagen (Col2) and green ﬂuorescent protein (GFP).
GFP-positive cells expressing Col2 were found in the femoral condyles in the M þ PRP and M groups (arrow). Bars ¼ 20 mm. (B) Quantiﬁcation of the number of double-positive cells
staining for both type II collagen and GFP demonstrated that the M þ PRP group showed a higher number of GFP labeled cells differentiated into Col2 expressing cells (chon-
drocytes) compared to the M group (not signiﬁcant. n ¼ 6 knees in each group). (C) The total number of Col2-positive cells was signiﬁcantly higher in the M þ PRP group compared
to the other groups (n ¼ 6 knees in each group). (D) Chondrocyte apoptosis was less abundant in the superﬁcial/mid zone of the femoral condyle in the M þ PRP group when
compared with the other groups. Bars ¼ 40 mm. (E) Quantiﬁcation of the TUNEL stained cells showed that the M þ PRP group showed signiﬁcantly fewer apoptotic chondrocytes
compared to the PRP and the PBS groups (n ¼ 6 knees in each group).
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and the number of GFP/b-gal positive cells was signiﬁcantly greater
in the MesFlt1/B4 þ PRP group than the MesFlt1/B4 group(P ¼ 0.0220) [Fig. 4(D)]. The total number of Col2-positive cells was
signiﬁcantly higher in the MesFlt1/B4 þ PRP group compared to
the MesFlt1/B4 group (P ¼ 0.0180) [Fig. 4(E)].
Fig. 3. Macroscopic and histologic evaluation of gene-transducedMDSC therapy. (A) Fourweeks afterMDSC transplantation, macroscopic evaluation of theMesFlt1/B4þ PRP and
MesFlt1/B4 groups revealed smooth joint surfaces of AC and no osteophyte formation, and 12weeks after transplantation, rat knees treatedwithMesFlt1/B4þ PRP orMesFlt1/B4 still
showed smooth joint surfaces. (B) Histologic assessment at week 4 demonstrated that Safranin O-positive hyaline-like cartilagewas present in theMesFlt1/B4þ PRP andMesFlt1/B4
groups, and histologic assessment at week 12 also demonstrated thatmore Safranin O-positive tissue and few clusters of chondrocytes near necrotic tissuewere found in theMesFlt1/
B4þ PRP andMesFlt1/B4 groups. Originalmagniﬁcation 100. (C) Fourweeks following transplantation, the score of theMesFlt1/B4þ PRP groupwas also signiﬁcantly better than the
MesFlt1/B4 group. Twelveweeks following transplantation, therewas no signiﬁcant difference between theMesFlt1/B4þ PRP and theMesFlt1/B4 groups (n¼ 6 knees in each group).
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and sFlt1 transduced MDSCs
Chondrocyte apoptosis was less abundant in the MesFlt1/
B4 þ PRP group [Fig. 4(F)]. Quantiﬁcation of the TUNEL stained
cells showed that there were signiﬁcantly fewer apoptotic chon-
drocytes in the MesFlt1/B4 þ PRP group than in the MesFlt1/B4
group (P ¼ 0.0120) [Fig. 4(G)].
Mixed pellet culture experiments
To assess the reciprocal effects between MDSCs and OA chon-
drocytes (OA-C) with/without PRP, we performed mixed-cell pellet
culture experiments. As a control group, we set OA-C group which
included OA chondrocytes alone, not mixed with MDSCs. All cell
groups tested formed pellets. The pellets in the MeB4 þ PRP, MeB4
and MesFlt1 þ PRP groups were signiﬁcantly larger than the Me
sFlt1, M þ PRP, M and OA-C groups (P ¼ 0.0026 for MeB4 þ PRP vs
M þ PRP; P < 0.001 for MeB4 þ PRP vs MesFlt1, M and OA-C;
P ¼ 0.0108 for MeB4 vs M þ PRP; P ¼ 0.0027 for MeB4 vs MesFlt1;
P < 0.001 for MeB4 vs M and OA-C; P ¼ 0.0140 for MesFlt1 þ PRP
vs M þ PRP; P ¼ 0.0036 for MesFlt1 þ PRP vs MesFlt1; P < 0.001
for MesFlt1þ PRP vs M and OA-C). The pellets in the MesFlt1 group
were signiﬁcantly larger than theM and OA-C groups. (P¼ 0.0285 forMesFlt1 vs M; P < 0.001 for MesFlt1 vs OA-C) [Fig. 5(A)]. The pellets
from every group showed hyaline cartilage-like extracellular matrix
(ECM) that stained positively for Alcian blue and contained well-
differentiated, round chondrocyte-like cells [Fig. 5(B)].
To analyze the effect of PRP on chondrocyte apoptosis in cultured
pellets, TUNEL staining was performed using pellet samples ob-
tained 3 weeks after cultivation. Chondrocyte apoptosis was less
abundant in the MesFlt1 þ PRP and MesFlt1 groups [Fig. 5(B)].
Quantiﬁcation of the TUNEL stained cells showed that the Me
sFlt1 þ PRP and MesFlt1 groups showed fewer apoptotic
cells compared with the other treatment groups (P < 0.001 for Me
sFlt1þ PRP vsMeB4þ PRP; P¼ 0.0018 forMesFlt1þ PRP vsMeB4;
P ¼ 0.0021 for MesFlt1 þ PRP vs M þ PRP; P ¼ 0.0452 for Me
sFlt1 þ PRP vs M; P ¼ 0.0110 for MesFlt1 þ PRP vs OA-C;
P < 0.001 for MesFlt1 vs MeB4 þ PRP, MeB4, M þ PRP and OA-C;
P ¼ 0.0170 for MesFlt1 vs M). The number of apoptotic cells was
signiﬁcantly higher in theMeB4þ PRP group than theMeB4 group,
as well as in the M þ PRP group than the M groups (P ¼ 0.0072 for
MeB4þPRPvsMeB4; P¼0.0448 forMþPRPvsM); however, there
was no signiﬁcant difference between the MesFlt1 þ PRP and Me
sFlt1 groups (P ¼ 0.3874 for MesFlt1 þ PRP vs MesFlt1) [Fig. 5(C)].
Immunohistochemical staining for Col2 showed that collagen
synthesis within the pellets was enhanced in the MeB4 þ PRP and
MeB4 groups [Fig. 5(B)]. Quantitative analysis revealed that there
Fig. 4. Cell contribution of gene-transduced MDSCs and chondrocyte apoptosis analysis. (A) Double immunohistochemical staining for Col2 and GFP. The BMP-4 transduced
MDSCs and the control MDSCs were also transduced to express GFP. GFP-positive cells expressing Col2 were found in the femoral condyles in the MesFlt1/B4 þ PRP and MesFlt1/B4
groups (arrow). Bars ¼ 20 mm. (B) The sFlt1 transduced MDSCs were also transduced to express b-gal. b-gal positive cells expressing Col2 were found in the femoral condyles in the
MesFlt1/B4 þ PRP and MesFlt1/B4 groups (arrow). Bars ¼ 20 mm. (C) Quantiﬁcation of the number of double-positive cells of Col2 and GFP/b-gal demonstrated that the MesFlt1/
B4 þ PRP and the MesFlt1/B4 groups showed a signiﬁcantly higher number of GFP/b-gal labeled cells differentiated into Col2 expressing cells (chondrocytes) compared to the other
groups. The number of double-positive cells in the MesFlt1/B4 þ PRP group was also signiﬁcantly higher than the MesFlt1/B4 group (n ¼ 6 knees in each group). (D) The number of
GFP/b-gal positive cells in the MesFlt1/B4 þ PRP group was signiﬁcantly higher than the MesFlt1/B4 group (n ¼ 6 knees in each group). (E) The MesFlt1/B4 þ PRP group showed
a signiﬁcantly higher number of Col2-positive cells than the MesFlt1/B4 group (n ¼ 6 knees in each group). (F) Chondrocyte apoptosis was less abundant in the superﬁcial/mid zone
of the femoral condyle, especially in the MesFlt1/B4 þ PRP group. Bars ¼ 40 mm. (G) Quantiﬁcation of the TUNEL stained cells showed that the MesFlt1/B4 þ PRP and the MesFlt1/
B4 groups showed signiﬁcantly fewer apoptotic chondrocytes compared to the other treatment groups. The number of apoptotic chondrocytes was signiﬁcantly fewer in the Me
sFlt1/B4 þ PRP group than the MesFlt1/B4 group (n ¼ 6 knees in each group).
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groups, as well as between the M þ PRP and M groups (P ¼ 0.2246
for MeB4 þ PRP vs MeB4; P ¼ 0.1538 for M þ PRP vs M); however,
the number of Col2-positive cells was signiﬁcantly higher in the
MesFlt1 þ PRP group than the MesFlt1 group (P ¼ 0.0315 for Me
sFlt1 þ PRP vs MesFlt1) [Fig. 5(D)].Discussion
In the present study, we initially determined whether PRP can
improve the beneﬁcial effect imparted byMDSCs for AC repair after
OA induction by comparing the regenerative potential of
MDSCs þ PRP treatment with the MDSCs alone. Although
Fig. 5. Mixed pellet co-culture. (A) The pellets in the MeB4 þ PRP, MeB4 and MesFlt1 þ PRP groups were signiﬁcantly larger than the MesFlt1, M þ PRP, M and OA-C groups. The
pellets in the MesFlt1 group were signiﬁcantly larger than the M and OA-C groups (n ¼ 3 in each group). (B) Morphologically pellets were formed in all groups, and the pellets from
every group showed hyaline cartilage-like ECM that stained positively for Alcian blue. Cell apoptosis assessed by TUNEL staining was less abundant in theMesFlt1þ PRP andMesFlt1
groups. Immunohistochemical staining for Col2 showed that collagen synthesis within the pellets was enhanced in the MeB4 þ PRP and MeB4 groups. Bars ¼ 50 mm. (C)
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observed in the M þ PRP group when compared to the M alone
group, no signiﬁcant difference was noted between these two
groups in the histological assessment of AC repair and cell
apoptosis analysis (Figs. 1 and 2). These results suggest that PRP
provided only a limited effect on the regenerative potential of
MDSCs in cartilage repair after OA induction. Since PRP contains
angiogenic factors that can have deleterious effects on the AC repair
process, and BMP-4 has been found important for MDSC mediated
AC repair, we performed additional experiments where sFlt1 (an
angiogenic antagonist) and BMP-4 were added to the PRP and
MDSCs. Our results indicate that the combination of PRP and BMP-
4/sFlt1 expressing MDSCs results in a signiﬁcantly better beneﬁcial
effect on AC repair when compared to all the other groups tested;
however, the beneﬁcial effect that PRP has on MDSCs expressing
BMP-4 and sFlt1 appears to be transient since the histological
assessment of AC repair was found to not be signiﬁcantly different
than the BMP-4 and sFlt1 expressing MDSCs at 12 weeks post-
transplantation. From these results, we concluded that PRP could
work more effectively for MDSC mediated cartilage repair when
combined with BMP-4/sFlt1, and that the inﬂuence of PRP may not
have lasted over the 12-week period of the experiment since the
PRP was injected only once into knee capsule in this study.
Our study also revealed a lack of beneﬁcial effects exhibited by
the PRP group on AC repair at both 4 and 12 weeks after injection
which is in contrast to prior manuscripts that reported PRP’s
effectiveness for cartilage repair12,26; however, in these studies the
investigators administered PRP multiple times or via biodegradable
scaffolds. Therefore, we believe that this disparity is related to the
frequency of PRP administration and the use of a scaffold. Hence,
continuous PRP administration should be considered an important
inﬂuential factor for future clinical applications of PRP for AC repair.
In the in vivo apoptosis assay, chondrocyte apoptosis was
signiﬁcantly reduced in the M þ PRP group when compared with
the PRP and PBS groups but there was no signiﬁcant difference
between the M þ PRP and the M groups (Fig. 2). On the other hand,
the MesFlt1/B4 þ PRP group showed a signiﬁcant reduction in
chondrocyte apoptosis compared with the MesFlt1/B4 group
(Fig. 4). In our previous study, we reported that VEGF induced
higher levels of chondrocyte apoptosis in the OA knee than all the
other groups and that sFlt1-treated OA knees showed the lowest
level of chondrocyte apoptosis23. It has been reported that VEGF
increases the catabolic pathway in AC tissue through the stimula-
tion of Matrix metalloproteinases (MMP) activity and the reduction
of tissue inhibitors of metalloproteinases (TIMPs), which conse-
quently leads to cartilage destruction by enhancing angiogenesis
and vascular invasion23,27,28. Taken together, we posited that the
enhancement of chondrocyte apoptosis by PRP was suppressed by
sFlt1 in the MesFlt1/B4 þ PRP group and believe this could
represent amajormechanism of why PRP’s effect is enhancedwhen
used in combination with sFlt1 for AC repair.
In order to clarify the interactions that PRP, BMP-4 and sFlt1 have
onMDSCmediated AC repair, we performed in vitro studies to assay
for cell proliferation, adhesion andmigration, aswell aswith a pellet
culture system. The results indicated that PRP induced higher levels
of MDSC proliferation, adhesion and migration (Supplementary
Fig. AeC). These PRP related effects potentially enhanced the BMP-
4/sFlt1 expressing MDSCs direct contribution to the cartilage
repair process in our in vivo experiments. These results are in
agreement with reports showing that PRP enhances cell prolifera-
tion and migration of bone marrow MSCs, adipose-derived stemQuantiﬁcation of the TUNEL stained cells showed that the MesFlt1 þ PRP and MesFlt1 group
increased TUNEL stained cells (n ¼ 3 in each group). (D) Quantitative analysis revealed that t
between the M þ PRP and M groups. Whereas the number of Col2-positive cells was signiﬁccells, osteoblasts and chondrocytes29e32. Also, another paper re-
ported that PRP could promote cell adhesion and migration of
ﬁbroblasts33.
In the pellet culture assay, PRP þ sFlt1 had a signiﬁcant effect on
the size of the pellets formed, while PRP alone had no signiﬁcant
effect on the pellet size (Fig. 5). Mishra et al. reported that PRP could
enhance the chondrogenic differentiation of MSCs34, and that TGF-
beta and ﬁbroblast growth factor (FGF) signaling, which are factors
present within PRP, are important for chondrogenic differentiation
of MSCs35. On the other hand, the increased pellet size observed in
our experiment may not be entirely related to chondrogenic
differentiation of the MDSCs but could also represent an indirect
effect that PRP had on cell proliferation and ECM production;
therefore, the entire effect that PRP has on the chondrogenic
potential of MDSCs is still unclear and further studies are required.
This pellet culture assay also demonstrated that PRP had an effect
that increased the number of apoptotic cells in the chondrocyte
pellets, which in turn was reduced with the addition of sFlt1
(Fig. 5). Interestingly, this ﬁnding was inconsistent with our
in vivo results that showed that PRP did not promote cell apoptosis
during cartilage repair. Recently, it was reported that PRP could
affect synovial ﬁbroblasts to increase hyaluronic acid production36
and also promote chondrocytes to maintain their phenotype and to
inhibit cellular de-differentiation37. In our in vivo study, PRP could
have some effects, not only on the transplanted MDSCs, but also on
the joint tissues including synovium, fat pad, bone marrow as well
as the AC, which could potentially suppress the effects of PRP on
chondrocyte apoptosis. Additional experiments are required to test
the effectiveness of PRP on the healing of these other intra-articular
structures.
We also revealed that PRP could promote collagen synthesis
(Fig. 5). Some growth factors included in PRP, such as TGF-b1, IGF-I,
BMP-2 and -7, have already been reported to have an effect of
promoting collagen synthesis38,39, which supports our ﬁndings that
PRP enhances collagen synthesis. This increase of collagen synthesis
could represent another mechanism by which PRP enhances AC
healing.
Recently, PRP has been reported to be effective for the treatment
of AC. Sanchez et al. showed the effectiveness of intra-articular
injections of an autologous preparation rich in growth factors for
the treatment of OA in the knee, in retrospective matched cohort
study40. Furthermore, Kon et al. reported that the use of PRP
injections was safe and had the potential to reduce pain and
improve knee function and quality of life in younger patients with
low degrees of AC degeneration41; however, further studies are
necessary to clarify the clinical application of PRP and to better
understand its mechanism of action. For example, it has been
shown that platelets could potentially be involved in the induction
of arthritis42.
Several limitations should be noted in this study. Firstly, we did
not include a group that utilized MDSCs that expressed sFlt1 alone
or with sFlt1 and PRP in our in vivo studies. Our previous studies
have suggested that BMP-4 has a critical effect onMDSC therapy for
cartilage repair; therefore we considered the addition of BMP-4 to
be indispensable for this type of cell therapy to treat OA. To eluci-
date the mechanisms of this combined therapy, we performed
in vitro studies using either BMP-4 or sFlt1 separately. The second
limitation to our study was the fact that our OA model was
chemically induced which is thought to be less clinically relevant
than surgically induced OA models which better resemble the
pathophysiology of OA; however, the reproducibility of the grades showed fewer apoptotic cells compared with the other treatment groups, and that PRP
here is no signiﬁcant difference between the MeB4 þ PRP and MeB4 groups, as well as
antly higher in the MesFlt1 þ PRP group than the MesFlt1 group (n ¼ 3 in each group).
Y. Mifune et al. / Osteoarthritis and Cartilage 21 (2013) 175e185184and stage of OA achieved using the chemically induced model in
immunodeﬁcient rats was highly consistent with previous reports
of OA in other rat strains43,44. In this study, we used bilateral knees
in a rat, accordingly we cannot exclude the possibility of an inﬂu-
ence from the opposite treatment side of the animal. The third
limitation to this study was the fact that the PRP used in this study
was not characterized for its composition and physical character-
istics. Besides variations between donors, there have been a variety
of ways to isolate PRP reported; hence the composition of the PRPs
isolated will differ from one another in composition. The advantage
of PRP is its ready accessibility, simple preparation and that it is an
autologously-derived material; however, standardized methods for
isolating PRP are required.
In conclusion, our ﬁndings indicate that PRP can promote the
therapeutic effect of MDSCs expressing BMP-4 and sFlt1 for chon-
dral repair 4 weeks after transplantation via the promotion of
collagen synthesis and the suppression of chondrocyte apoptosis;
however, the PRP effects are only transient since at 12 weeks the
beneﬁcial effect of the PRP is lost.Author contributions
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